Merck KGaA's revenues fall flat despite Serono rise
This article was originally published in Scrip
Executive Summary
Merck KGaA's revenues were once again flat in the second quarter and first half at €1.90 billion and €3.76 billion respectively, owing to poor sales of its liquid crystals and consumer healthcare businesses.